RECRUITING

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

Talk to us

Conditions

Parkinson Diseasegeneticsracial health disparities

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.

Official Title

Black and African Americans Connections to Parkinson's Disease (BLAAC PD) a Project of the Global Parkinson's Genetics Program (GP2)

Quick Facts

Study Start:2020-11-16
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06719583

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Naomi Louie, MPH RDN
CONTACT
212-509-0995
nlouie@michaeljfox.org
J Solle, MBA
CONTACT
jsolle@michaeljfox.org

Principal Investigator

Andrew Singleton, PhD
PRINCIPAL_INVESTIGATOR
National Institutes of Health (NIH)

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35233
United States
University of Florida
Gainesville, Florida, 32608
United States
Rush University
Chicago, Illinois, 60612
United States
University of Chicago
Chicago, Illinois, 60637
United States
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121
United States
Louisiana State University Health Sciences Center Shreveport
Shreveport, Louisiana, 71103
United States
University of Maryland
Baltimore, Maryland, 21201
United States
Kaiser Permanente Midatlantic States
Rockville, Maryland, 20852
United States
Washington University in St. Louis
Saint Louis, Missouri, 63119
United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106
United States
Medical University of South Carolina
Charleston, South Carolina, 29425
United States
University of Texas Health Science Center, Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Michael J. Fox Foundation for Parkinson's Research

  • Andrew Singleton, PhD, PRINCIPAL_INVESTIGATOR, National Institutes of Health (NIH)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-11-16
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2020-11-16
Study Completion Date2026-12-31

Terms related to this study

Keywords Provided by Researchers

  • genetics
  • racial health disparities

Additional Relevant MeSH Terms

  • Parkinson Disease